Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 83 | 0 | 0 | 4 | 24 |
| Cost of Goods | 13 | N/A | N/A | 2 | 16 |
| Gross Profit | 70 | N/A | N/A | 2 | 9 |
| Operating Expenses | 4,243 | 4,604 | 5,411 | 2,569 | 2,215 |
| Operating Income | -4,159 | -4,604 | -5,411 | -2,565 | -2,191 |
| Interest Expense | 5,197 | 5,789 | 2,395 | 1,542 | 179 |
| Other Income | 2,921 | -417 | 2,490 | -2,659 | 1,411 |
| Pre-tax Income | -6,436 | -10,810 | -5,316 | -6,766 | -960 |
| Net Income Continuous | -6,436 | -10,810 | -5,316 | -6,766 | -960 |
| Net Income | $-6,436 | $-10,810 | $-5,316 | $-6,766 | $-960 |
| EPS Basic Total Ops | -17.76 | -40.00 | -50.00 | -70.00 | -30.00 |
| EPS Basic Continuous Ops | -17.78 | -44.65 | -45.28 | -69.86 | -31.68 |
| EPS Diluted Total Ops | -17.76 | -40.00 | -50.00 | -70.00 | -30.00 |
| EPS Diluted Continuous Ops | -17.78 | -44.65 | -45.28 | -69.86 | -31.68 |
| EBITDA(a) | $52 | $-2,423 | $-4,340 | $-2,550 | $-2,176 |